<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03638947</url>
  </required_header>
  <id_info>
    <org_study_id>201802843</org_study_id>
    <nct_id>NCT03638947</nct_id>
  </id_info>
  <brief_title>Reducing Perioperative S. Aureus Transmission</brief_title>
  <official_title>Reducing Perioperative S. Aureus Transmission Via Use of an Evidence-Based, Multimodal Program Driven by an Innovative Software Platform (OR Path Trac)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Randy Loftus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>RDB Bioinformatics, LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to prevent the spread of S. aureus, a dangerous bacterium,
      within the operating room and between patients undergoing surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to prevent the spread of S. aureus, a dangerous bacterium,
      within the operating room and between patients undergoing surgery. The investigators will
      combine several approaches in a &quot;bundle&quot; of activities to achieve this goal. The bundle will
      include removal of bacterial pathogens from patient skin sites before surgery, from provider
      hands before, during, and after surgery, from environmental surfaces before and after
      terminal cleaning, and from the injection ports of patient intravenous catheters. The
      investigators will use a new surveillance system to evaluate how well the bundle, and each
      component of the bundle, is working. Surveillance will identify S. aureus transmission
      events, and movement of S. aureus between reservoirs before, during, and after surgery
      (perioperative). Surveillance will map transmission events to identify actionable steps to
      improve the bundle. An infection control perioperative team will act on the surveillance
      reports to proactively address the action items, and to measure the effect of their efforts
      for the treatment group. The investigators will compare perioperative S. aureus transmission
      events for patients receiving the bundle to perioperative S. aureus transmission events for
      patients receiving usual care.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 20, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>After the patient has signed consent, they will receive a pre-surgical kit that will include swabs to be used in the nares, arm pit and groin area (standard of care). In a 1:1 randomization scheme, one half of the patients will receive povidone-iodine swab in addition to the kit (treatment).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Identify the number of perioperative S. aureus reservoirs using collection kits</measure>
    <time_frame>Perioperative time.</time_frame>
    <description>To identify locations that harbor S. aureus reservoirs immediately prior to surgery and during the operative procedure, the investigators will surveil the patient's skin, surgical team's hands, injection ports of the patient's catheters and environmental sites within the operating room suite using sterile collection kits.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Map the number of S. aureus transmission events using OR Path Trac software</measure>
    <time_frame>Up to 180 days following surgery</time_frame>
    <description>OR Path Trac software algorithms will map how S. aureus is transmitted from an initially identified reservoir to another location within the perioperative arena.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitate the reduction of S. aureus tranmission</measure>
    <time_frame>Up to 180 days following surgery</time_frame>
    <description>Compare the number of S. aureus transmission events for patients who receive the standard presurgical preparation verses patients who receive decolonization interventions.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">236</enrollment>
  <condition>Staphylococcus Aureus</condition>
  <condition>Health Care Associated Infection</condition>
  <condition>Health Care Worker Patient Transmission</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient will receive by mail a kit containing swab for the nares, armpit and groin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Swab kit plus povidone-iodine soap</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will receive by mail a kit containing swab for the nares, armpit and groin. In addition the patient will receive decolonization treatment including povidone-iodine soap for presurgical cleansing two days prior to surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Swab and decolonization using povidone-iodine cleansing</intervention_name>
    <description>Patient in this group will receive improved environmental cleaning and undergo surveillance using swabs and decolonization cleansing.</description>
    <arm_group_label>Swab kit plus povidone-iodine soap</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years of age

          -  Undergoing surgery (orthopedic total joint, orthopedic spine, Gynecological/Oncology,
             thoracic, general, hernia, colorectal, open vascular, plastic surgery and open
             urological)

          -  Ability to sign informed consent

          -  Require general or regional anesthesia

        Exclusion Criteria:

          -  Less than 18 years of age

          -  Inability to sign informed consent

          -  Procedures not included above

          -  Not requiring general or regional anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randy Loftus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://obamawhitehouse.archives.gov/the-press-office/2014/09/18/fact-sheet-obama-administration-takes-actions-combat-antibiotic-resistan</url>
    <description>Fact Sheet: Obama Administration Takes Actions to Combat Antibiotic-Resistant Bacteria</description>
  </link>
  <link>
    <url>https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm</url>
    <description>Updated Guidelines for Evaluating Public Health Surveillance Systems</description>
  </link>
  <link>
    <url>http://www.who.int/drugresistance/documents/surveillancereport/en/</url>
    <description>Antimicrobial resistance: global report on surveillance 2014</description>
  </link>
  <reference>
    <citation>Vogel TR, Dombrovskiy VY, Lowry SF. Impact of infectious complications after elective surgery on hospital readmission and late deaths in the U.S. Medicare population. Surg Infect (Larchmt). 2012 Oct;13(5):307-11. doi: 10.1089/sur.2012.116. Epub 2012 Oct 19.</citation>
    <PMID>23082877</PMID>
  </reference>
  <reference>
    <citation>Koff MD, Brown JR, Marshall EJ, O'Malley AJ, Jensen JT, Heard SO, Longtine K, O'Neill M, Longtine J, Houston D, Robison C, Moulton E, Patel HM, Loftus RW. Frequency of Hand Decontamination of Intraoperative Providers and Reduction of Postoperative Healthcare-Associated Infections: A Randomized Clinical Trial of a Novel Hand Hygiene System. Infect Control Hosp Epidemiol. 2016 Aug;37(8):888-95. doi: 10.1017/ice.2016.106. Epub 2016 Jun 7.</citation>
    <PMID>27267310</PMID>
  </reference>
  <reference>
    <citation>Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999 Nov;20(11):725-30.</citation>
    <PMID>10580621</PMID>
  </reference>
  <reference>
    <citation>Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009 Jan 1;48(1):1-12. doi: 10.1086/595011. Review.</citation>
    <PMID>19035777</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Koff MD, Burchman CC, Schwartzman JD, Thorum V, Read ME, Wood TA, Beach ML. Transmission of pathogenic bacterial organisms in the anesthesia work area. Anesthesiology. 2008 Sep;109(3):399-407. doi: 10.1097/ALN.0b013e318182c855.</citation>
    <PMID>18719437</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Brown JR, Koff MD, Reddy S, Heard SO, Patel HM, Fernandez PG, Beach ML, Corwin HL, Jensen JT, Kispert D, Huysman B, Dodds TM, Ruoff KL, Yeager MP. Multiple reservoirs contribute to intraoperative bacterial transmission. Anesth Analg. 2012 Jun;114(6):1236-48. doi: 10.1213/ANE.0b013e31824970a2. Epub 2012 Mar 30.</citation>
    <PMID>22467892</PMID>
  </reference>
  <reference>
    <citation>Clark C, Taenzer A, Charette K, Whitty M. Decreasing contamination of the anesthesia environment. Am J Infect Control. 2014 Nov;42(11):1223-5. doi: 10.1016/j.ajic.2014.07.016. Epub 2014 Oct 30.</citation>
    <PMID>25444268</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Dexter F, Robinson ADM. High-risk Staphylococcus aureus transmission in the operating room: A call for widespread improvements in perioperative hand hygiene and patient decolonization practices. Am J Infect Control. 2018 Oct;46(10):1134-1141. doi: 10.1016/j.ajic.2018.04.211. Epub 2018 Jun 12.</citation>
    <PMID>29907449</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Dexter F, Robinson ADM. Methicillin-resistant Staphylococcus aureus has greater risk of transmission in the operating room than methicillin-sensitive S aureus. Am J Infect Control. 2018 May;46(5):520-525. doi: 10.1016/j.ajic.2017.11.002. Epub 2018 Jan 4.</citation>
    <PMID>29307750</PMID>
  </reference>
  <reference>
    <citation>Hadder B, Patel HM, Loftus RW. Dynamics of intraoperative Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter transmission. Am J Infect Control. 2018 May;46(5):526-532. doi: 10.1016/j.ajic.2017.10.018. Epub 2018 Feb 12.</citation>
    <PMID>29395508</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Muffly MK, Brown JR, Beach ML, Koff MD, Corwin HL, Surgenor SD, Kirkland KB, Yeager MP. Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission. Anesth Analg. 2011 Jan;112(1):98-105. doi: 10.1213/ANE.0b013e3181e7ce18. Epub 2010 Aug 4.</citation>
    <PMID>20686007</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 15, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2018</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Randy Loftus</investigator_full_name>
    <investigator_title>Clinical Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cross Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data collected during the trial, after deidentification will be shared with researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal. IPD will be available for sharing immediately after publication and ending 5 years following article publication.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>IPD will be available for sharing immediately after publication and ending 5 years following article publication.</ipd_time_frame>
    <ipd_access_criteria>IPD will be accessible to researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

